+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07844473

Evaluating Magtrace for Tumor Bracketing and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer - The MagBracket Study

Led by King Faisal Specialist Hospital & Research Center · Updated on 2026-09-28

35

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Breast cancer is the most common cancer affecting women worldwide, and early-stage breast cancer is typically treated with breast-conserving surgery and sentinel lymph node biopsy to minimize surgical impact while ensuring complete tumor removal and accurate staging. This study evaluates the use of Super Paramagnetic Iron Oxide SPIO, specifically Magtrace, as a single agent for both bracketing the tumor area and localizing the sentinel lymph node. The goal is to test whether this dual-purpose approach is feasible and effective compared to current methods that use multiple localization tools. Participants who need bracketing for wide local excision along with sentinel lymph node biopsy will receive Magtrace injections at four points around the tumor area one day before surgery under ultrasound or mammographic guidance. On the day of surgery, surgeons will use a magnetic probe to locate the Magtrace signal for both the lesion and sentinel lymph node. If localization fails, alternative methods may be used. Surgery will follow standard techniques, and a blue dye will also be used to confirm sentinel node detection. The study aims to recruit 35 patients for this prospective pilot trial. During the study, participants will undergo localization procedures before surgery, surgical excision, and sentinel node biopsy with ongoing monitoring of localization success, surgical duration, tissue removal, margin status, reoperation rates, and postoperative complications up to three months. Data on clinical outcomes, complications, and cost will be collected and analyzed. The study will last approximately 2 to 3 years, including recruitment and follow-up, with results intended for publication and broader sharing.

CONDITIONS

Brief Title

Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer

Research Team

F

Fayyaz A Mazari, MBBS, MSc, MS, PhD, FRCS, FEBS

Z

Zabihullah Khan, MBBS FRCS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here